newsfilter
← Latest News
Business Wire·

Paracrine Announces Appointment of Biotech Veteran David Crean, Ph.D. to the Board of Directors

Paracrine, Inc., a company developing its novel cell therapy platform in late-stage clinical trials in advanced wound care, announced today the appointment of David Crean, Ph.D. as an independent Director of the company. "We are delighted to welcome